Table 4.
Clinical characteristics of patients with COVID-19 and differences in clinical features between patients with mild–moderate CTSS and severe CTSS
| Clinical characteristics | All patients (n=92), N (%) | CT score (mild–moderate) (n=23), N (%) | CT score (severe) (n=69), N (%) | P |
|---|---|---|---|---|
| Sex | ||||
| Female | 16 (17.4) | 6 (37.5) | 10 (62.5) | 0.20 |
| Male | 76 (82.6) | 17 (22.4) | 59 (77.6) | |
| Comorbidities | ||||
| Hypertension | 51 (55.4) | 13 (25.5) | 38 (74.5) | 0.90 |
| Diabetes | 28 (30.4) | 4 (14.3) | 24 (85.7) | 0.11 |
| COPD | 5 (5.4) | 4 (4.3) | 1 (1.1) | 0.003 |
| DVT | 3 (3.3) | 2 (2.2) | 1 (1.1) | 0.09 |
| CAD | 3 (3.3) | 1 (1.1) | 2 (2.2) | 0.73 |
| Stroke | 2 (2.2) | – | 2 (2.2) | 0.40 |
| Clinical outcomes | ||||
| Mechanical ventilation | 25 (27.2) | 2 (8) | 23 (92) | 0.02 |
| Discharge | 74 (80.4) | 21 (28.4) | 53 (71.6) | 0.12 |
| Death | 18 (19.6) | 2 (11.1) | 16 (88.9) | 0.12 |
| Anticoagulation therapeutic | 17 (18.5) | – | 17 (100) | 0.008 |
| Anticoagulation prophylactic | 75 (81.5) | 23 (30.7) | 52 (69.3) | 0.008 |
CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; COVID-19, coronavirus disease 2019; CT, computed tomography; DVT, deep vein thrombosis.